Here are three things to note about televised prescription drug advertisements today.
1. Kantar Media records 771,368 airings of prescription drug commercials in 2016, the last full year for which data is available. “Spending by pharmaceutical companies has more than doubled in the past four years, making it the second-fastest-growing category on television during that time,” Jon Swallen, Kantar’s chief research officer, told NYT.
2. Ads are keeping pace with health issues more likely experienced by drugmakers’ prime audience of consumers ages 65 and older. “In the old days, it was allergies and acid reflux and whatnot,” Thomas Lom, a consultant and former senior executive at several healthcare ad agencies, told NYT. “Now, it’s cardiology issues. It’s cancer.”
3. The number of side effects listed in 60-second commercials evoke debate. As commercials today tout more critical health conditions, research suggests consumers experiencing specific conditions see the verbal listing of side effects as information that enhances advertiser credibility. At the same time, critics say these commercials compress a sizeable amount of serious information — more than is covered in commercials for any other industry — into a 60-second ad spot. This can run the risk of consumers experiencing this information as white noise.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.